Silvia Rojo‐Rello

1.5k total citations
26 papers, 175 citations indexed

About

Silvia Rojo‐Rello is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Silvia Rojo‐Rello has authored 26 papers receiving a total of 175 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 9 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in Silvia Rojo‐Rello's work include Influenza Virus Research Studies (10 papers), Respiratory viral infections research (9 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Silvia Rojo‐Rello is often cited by papers focused on Influenza Virus Research Studies (10 papers), Respiratory viral infections research (9 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Silvia Rojo‐Rello collaborates with scholars based in Spain, United States and Mongolia. Silvia Rojo‐Rello's co-authors include David Bernardo, Alberto Valdés, Antonio Orduña, Lorena Ortega Moreno, Alejandro Cifuentes, Iván Sanz-Muñoz, Elena Carnero‐Montoro, José Marı́a Eiros Bouza, Manuel Martínez‐Bueno and Guillermo Barturen and has published in prestigious journals such as Nature Communications, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Silvia Rojo‐Rello

24 papers receiving 172 citations

Peers

Silvia Rojo‐Rello
Silvia Rojo‐Rello
Citations per year, relative to Silvia Rojo‐Rello Silvia Rojo‐Rello (= 1×) peers Junbin Wang

Countries citing papers authored by Silvia Rojo‐Rello

Since Specialization
Citations

This map shows the geographic impact of Silvia Rojo‐Rello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Rojo‐Rello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Rojo‐Rello more than expected).

Fields of papers citing papers by Silvia Rojo‐Rello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Rojo‐Rello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Rojo‐Rello. The network helps show where Silvia Rojo‐Rello may publish in the future.

Co-authorship network of co-authors of Silvia Rojo‐Rello

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Rojo‐Rello. A scholar is included among the top collaborators of Silvia Rojo‐Rello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Rojo‐Rello. Silvia Rojo‐Rello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanz-Muñoz, Iván, et al.. (2025). A 15-year study of neuraminidase mutations and the increasing of S247N mutation in Spain. Virus Research. 358. 199599–199599. 2 indexed citations
2.
Marugán‐Miguelsanz, José Manuel, et al.. (2025). Universal administration of nirsevimab in infants: an analysis of hospitalisations and paediatric intensive care unit admissions for RSV-associated lower respiratory tract infections. European Journal of Pediatrics. 184(6). 345–345. 1 indexed citations
3.
Mengel, Martin, Rong Fan, Qing Liu, et al.. (2024). RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022. Infectious Diseases and Therapy. 13(9). 1983–1999. 5 indexed citations
4.
Mengel, Martin, Rong Fan, Qing Liu, et al.. (2024). Respiratory Syncytial Virus Risk Profile in Hospitalized Infants and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022. Infectious Diseases and Therapy. 13(11). 2395–2413. 1 indexed citations
5.
Sanz-Muñoz, Iván, Marta Hernández, Silvia Rojo‐Rello, et al.. (2024). Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?. mBio. 16(2). e0372124–e0372124. 8 indexed citations
6.
Sanz-Muñoz, Iván, et al.. (2024). Association of viral loads of influenza A (H3N2) with age and care setting on presentation—a prospective study during the 2022-2023 influenza season in Spain. International Journal of Infectious Diseases. 143. 107034–107034.
7.
García‐Azorín, David, Diego Macías Saint-Gerons, Silvia Rojo‐Rello, et al.. (2024). Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study. The Journal of Headache and Pain. 25(1). 18–18. 1 indexed citations
8.
Rojo‐Rello, Silvia, et al.. (2024). Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection. Scientific Reports. 14(1). 353–353. 4 indexed citations
9.
Rojo‐Rello, Silvia, et al.. (2023). Outcomes of viral coinfections in infants hospitalized for acute bronchiolitis. Virology Journal. 20(1). 235–235. 9 indexed citations
10.
García‐Azorín, David, et al.. (2023). InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infection. Cephalalgia. 43(11). 2215257956–2215257956. 2 indexed citations
11.
Sanz-Muñoz, Iván, Marta Domínguez‐Gil González, Silvia Rojo‐Rello, et al.. (2023). Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people. Frontiers in Immunology. 14. 1128302–1128302. 1 indexed citations
12.
Sanz-Muñoz, Iván, Silvia Rojo‐Rello, Marta Domínguez‐Gil, et al.. (2023). Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults. Human Vaccines & Immunotherapeutics. 19(2). 2236537–2236537. 4 indexed citations
13.
Gutiérrez-Jimeno, Miriam, et al.. (2023). Increase in severe acute respiratory infections in children during the last phase of the COVID-19 pandemic. Revista Española de Quimioterapia. 37(1). 58–68. 1 indexed citations
14.
Arribas‐Rodríguez, Elisa, Aida Fiz‐López, Javier Casas, et al.. (2022). Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge. International Journal of Molecular Sciences. 23(19). 11070–11070. 1 indexed citations
15.
Valdés, Alberto, Lorena Ortega Moreno, Silvia Rojo‐Rello, et al.. (2022). Metabolomics study of COVID-19 patients in four different clinical stages. Scientific Reports. 12(1). 1650–1650. 60 indexed citations
16.
Barturen, Guillermo, Elena Carnero‐Montoro, Manuel Martínez‐Bueno, et al.. (2022). Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection. Nature Communications. 13(1). 4597–4597. 28 indexed citations
17.
Morales, Albert, Silvia Rojo‐Rello, Aida Fiz‐López, et al.. (2021). Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome. Biomedicines. 9(4). 335–335. 24 indexed citations
18.
García, Sara Mallén, Marta Domínguez‐Gil González, Juan Luis Muñoz Bellido, et al.. (2018). Estudio comparativo de la prevalencia de virus de papiloma humano en las mujeres españolas y extranjeras, participantes en un programa de cribado poblacional en Castilla y León. Enfermedades Infecciosas y Microbiología Clínica. 37(5). 314–318. 2 indexed citations
19.
Sanz-Muñoz, Iván, Silvia Rojo‐Rello, & Raúl Ortíz de Lejarazu. (2018). Prevalence of antibodies and humoral response after seasonal trivalent vaccination against influenza B lineages in an elderly population of Spain. Enfermedades infecciosas y microbiologia clinica (English ed ). 36(9). 572–575. 1 indexed citations
20.
Sanz-Muñoz, Iván, Silvia Rojo‐Rello, & Raúl Ortíz de Lejarazu. (2017). Prevalence of antibodies and humoral response after seasonal trivalent vaccination against influenza B lineages in an elderly population of Spain. Enfermedades Infecciosas y Microbiología Clínica. 36(9). 572–575. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026